Hunter Associates Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Sell
4,598
-704
-13% -$56.8K 0.04% 240
2026
Q1
$461K Buy
5,302
+37
+0.7% +$3.54K 0.06% 198
2025
Q4
$506K Sell
5,265
-169
-3% -$16.4K 0.07% 184
2025
Q3
$520K Sell
5,434
-67
-1% -$6.16K 0.07% 182
2025
Q2
$479K Hold
5,501
0.07% 185
2025
Q1
$492K Sell
5,501
-1,172
-18% -$105K 0.08% 175
2024
Q4
$535K Sell
6,673
-586
-8% -$50.7K 0.08% 166
2024
Q3
$656K Hold
7,259
0.1% 152
2024
Q2
$571K Sell
7,259
-555
-7% -$45.5K 0.1% 163
2024
Q1
$680K Hold
7,814
0.11% 154
2023
Q4
$646K Buy
7,814
+191
+3% +$14.6K 0.12% 157
2023
Q3
$598K Sell
7,623
-650
-8% -$54.4K 0.12% 149
2023
Q2
$726K Hold
8,273
0.14% 133
2023
Q1
$664K Sell
8,273
-225
-3% -$18.3K 0.14% 127
2022
Q4
$658K Sell
8,498
-1,600
-16% -$130K 0.16% 117
2022
Q3
$812K Sell
10,098
-12
-0.1% -$1.08K 0.21% 92
2022
Q2
$906K Buy
10,110
+7,242
+253% +$734K 0.22% 88
2022
Q1
$318K Hold
2,868
0.1% 108
2021
Q4
$297K Sell
2,868
-6,068
-68% -$703K 0.08% 118
2021
Q3
$1.12M Buy
8,936
+3,200
+56% +$414K 0.36% 59
2021
Q2
$712K Sell
5,736
-5,477
-49% -$688K 0.22% 74
2021
Q1
$1.32M Buy
11,213
+590
+6% +$69.1K 0.31% 71
2020
Q4
$1.24M Sell
10,623
-265
-2% -$29.2K 0.31% 69
2020
Q3
$1.13M Hold
10,888
0.31% 66
2020
Q2
$998K Sell
10,888
-77
-0.7% -$7.38K 0.3% 72
2020
Q1
$989K Hold
10,965
0.38% 64
2019
Q4
$1.24M Sell
10,965
-60
-0.5% -$6.58K 0.39% 60
2019
Q3
$1.2M Hold
11,025
0.41% 59
2019
Q2
$1.07M Sell
11,025
-78
-0.7% -$7.12K 0.37% 60
2019
Q1
$1.01M Hold
11,103
0.35% 62
2018
Q4
$1.01M Hold
11,103
0.41% 58
2018
Q3
$1.09M Sell
11,103
-420
-4% -$38.8K 0.38% 65
2018
Q2
$986K Hold
11,523
0.36% 62
2018
Q1
$924K Buy
11,523
+88
+0.8% +$7.26K 0.35% 66
2017
Q4
$923K Buy
11,435
+361
+3% +$28.9K 0.34% 64
2017
Q3
$861K Hold
11,074
0.34% 64
2017
Q2
$983K Sell
11,074
-713
-6% -$60.1K 0.4% 57
2017
Q1
$950K Sell
11,787
-1,714
-13% -$134K 0.4% 60
2016
Q4
$962K Buy
13,501
+500
+4% +$39.3K 0.41% 58
2016
Q3
$1.12M Sell
13,001
-156
-1% -$13.6K 0.48% 53
2016
Q2
$1.14M Sell
13,157
-95
-0.7% -$7.68K 0.49% 55
2016
Q1
$994K Sell
13,252
-300
-2% -$22.6K 0.45% 57
2015
Q4
$1.04M Sell
13,552
-567
-4% -$42.7K 0.46% 51
2015
Q3
$945K Sell
14,119
-200
-1% -$14.7K 0.44% 51
2015
Q2
$1.06M Buy
14,319
+150
+1% +$11.5K 0.44% 54
2015
Q1
$1.1M Buy
+14,169
New +$1.07M 0.44% 56

Other funds holding MDT

Hunter Associates Investment Management's MDT Position: Q2 2026 in Review

Hunter Associates Investment Management reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $56.8K and leaving 4,598 shares worth $359K. The position accounts for 0.04% of the portfolio, ranked #240.

Hunter Associates Investment Management first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $1.32M in Q1 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hunter Associates Investment Management held 4,598 shares of Medtronic worth $359K as of Q2 2026.
  • Hunter Associates Investment Management sold 704 Medtronic shares in Q2 2026, an estimated $56.8K.
  • Medtronic made up 0.04% of Hunter Associates Investment Management's portfolio in Q2 2026, its #240 holding.
  • Hunter Associates Investment Management first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
  • Hunter Associates Investment Management's Medtronic position peaked at $1.32M in Q1 2021.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.